Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Refractory Pure Red Cell Aplasia
NCT03364764Phase 4Completed
- Start
- Feb 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus in pure red cell aplasia (PRCA). Started Feb 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT03364764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364764.